US · Regulatory authority
FDA regulatory signals
RegSig automatically extracts and normalizes regulatory signals from FDA—mapping updates on Additives, Health Claims, Nutrition Claims directly to product portfolios across 6 jurisdictions.
- 7 active signals
- US
- 4 topics
7
Active signals
4
Topics
6
Jurisdictions
US
Region
How RegSig covers FDA
RegSig's AI-native pipeline continuously ingests FDA publications, extracts regulatory actions, and normalizes them into scored signals with topic classification, time horizon, and jurisdiction context. Each signal is linked to source evidence and mapped against product portfolios so compliance teams can assess exposure without manual triage.
Representative signals from FDA
FDA Enforcement Focus on Additives Labeling Rules for Marketed Product Labels
Near-termAdditives
What changed: Regulators revised origin-claim and country-of-origin compliance conditions, updating what statements must be substantiated on pack and in supporting records.
Compliance Enforcement on Health Claims Requirements for Compliance Remediation
Near-termHealth Claims
What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.
Compliance Enforcement on Nutrition Labeling and Point-of-purchase Display Requirements for Label and
Long-termNutrition Claims
What changed: Nutrition labeling and point-of-purchase disclosure rules were revised, changing exemption tests and where mandatory nutrition information must appear for consumer products.
Enforcement Signal on Allergen Labeling Rules for Compliance Remediation
Near-termAllergen Labeling
What changed: A US federal instrument proposed or adopted updated requirements for how this topic must appear on pack or in supporting records.
FDA Guidance Proposal on Additives Labeling Rules for Federal Labeling Compliance
Near-termAdditives
What changed: A US federal instrument proposed or adopted updated requirements for how this topic must appear on pack or in supporting records.
FDA Proposed Shift on Health Claims Requirements for FDA-regulated Labels
Near-termHealth Claims
What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.
FDA Guidance Proposal on Health Claims Requirements for Us Market Labels
Near-termHealth Claims
What changed: Federal regulatory text on this topic was revised, updating labeling, claims, or compliance documentation expectations on affected products.
Full signal detail and portfolio mapping available after registration.
Regulatory topics from FDA
Jurisdictions in FDA signals
Explore more authorities
Individual access
Monitor FDA signals signals in your portfolio
RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.